SCHEMBL31000261

SCHEMBL31000261

COc1cc2ncc(-c3nc(Br)ncc3Cl)n2nc1C1CC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 20/20 0.38
▸ KCNH2 Q12809 10/20 0.38
▸ CDK2 P24941 2/20 0.34
▸ INSR P06213 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31000231 0.87 NRAS (0.34) IGF1RCDK2
SCHEMBL31000191 0.85 IGF1R (0.39) IGF1RKCNH2CDK2INSR
SCHEMBL31000292 0.84 PDE4B (0.39) IGF1RKCNH2CDK2INSR
SCHEMBL31000313 0.80 SUV39H2 (0.33) —
SCHEMBL31639175 0.79 NRAS (0.36) IGF1RCDK2
SCHEMBL31000211 0.78 IGF1R (0.32) IGF1RCDK2
SCHEMBL31000133 0.78 CDK7 (0.42) IGF1RKCNH2CDK2INSR
SCHEMBL31000128 0.78 IGF1R (0.32) IGF1RCDK2
SCHEMBL31739611 0.76 DYRK1A (0.37) —
SCHEMBL30698355 0.76 NRAS (0.36) IGF1RCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658659-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF Children's Hospital Medical Center (US) 2025-12-10 — — EP disclosed
WO-2024163764-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2024-08-08 — — WO disclosed
Send feedback